Lebwohl, M., Sugarman, J., Pariser, D., Bagel, J., Lin, T., & Israel, R. (2020). Safety and Tolerability of Fixed Combination Halobetasol Propionate 0.01% And Tazarotene 0.045% (HP/TAZ) Lotion in Patients With Moderate-to-Severe Plaque Psoriasis: Results From a 1-Year, Open-Label Study. SKIN The Journal of Cutaneous Medicine, 4(1), S12. Retrieved from https://www.jofskin.org/index.php/skin/article/view/826